UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
NeuroImage (Orlando, Fla.), ISSN 1053-8119, 2008, Volume 43, Issue 1, pp. 29 - 35
Mean diffusivity (MD) | Diffusion tensor image (DTI) | Fractional anisotropy (FA) | Malignant lymphoma | Glioma | Tumor cell density | Neuroimaging | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Science & Technology | Reproducibility of Results | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Brain Neoplasms - pathology | Child, Preschool | Male | Statistics as Topic | Algorithms | Cell Count - methods | Anisotropy | Sensitivity and Specificity | Adult | Female | Aged | Image Enhancement - methods | Diffusion Magnetic Resonance Imaging - methods | Child | Magnetic resonance imaging | Brain tumors | Brain | Software | Nuclear magnetic resonance--NMR | Brain cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 484 - 495
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Humans | Brain Neoplasms - pathology | Brain Neoplasms - genetics | Child, Preschool | Infant | Male | Combined Modality Therapy | Brain Neoplasms - surgery | Disease Progression | Canada | Disease-Free Survival | Magnetic Resonance Imaging | Brain Neoplasms - classification | Medulloblastoma - pathology | Adult | Female | Medulloblastoma - surgery | Retrospective Studies | Medulloblastoma - genetics | Child | Medulloblastoma - classification | Medulloblastoma | Surgery | Index Medicus
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 02/2020, Volume 71, Issue 2, pp. 757 - 759
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Liver Diseases - immunology | Bone Density Conservation Agents - adverse effects | Humans | Middle Aged | Autoimmune Diseases - complications | Bone Density Conservation Agents - therapeutic use | Treatment Outcome | Denosumab - adverse effects | Osteoporosis - etiology | Denosumab - administration & dosage | Time Factors | Liver Diseases - complications | Female | Aged | Osteoporosis | Liver diseases | Index Medicus | Clinical Observations in Hepatology
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 02/2019, Volume 68, Issue 2, pp. 331 - 340
Malignant glioma | Cancer vaccine | Peptide vaccine | Cancer immunotherapy | HLA class II peptide | WT1 | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Cancer vaccines | Medical research | Histocompatibility antigens | Peptides | Gliomas | Vaccination | HLA histocompatibility antigens | Clinical trials | Medicine, Experimental | Glioma | Toxicity | Histocompatibility antigen HLA | Safety | Vaccines | Index Medicus | Clinical Trial Report
Journal Article
Acta neuropathologica communications, ISSN 2051-5960, 08/2016, Volume 4, Issue 1, pp. 79 - 79
Molecular classification | Glioma | TERT | IDH1/2 | Glioblastoma | Prognostic factor | Temozolomide | 1p19q | Dacarbazine - therapeutic use | Humans | Middle Aged | DNA Repair Enzymes - genetics | Male | Glioblastoma - radiotherapy | Brain Neoplasms - surgery | DNA Methylation | Telomerase - genetics | Glioblastoma - genetics | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Adult | Female | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Japan | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Combined Modality Therapy | Brain Neoplasms - drug therapy | Glioblastoma - surgery | Antineoplastic Agents, Alkylating - therapeutic use | DNA Modification Methylases - genetics | Survival Analysis | Biomarkers, Tumor - genetics | Mutation | Glioblastoma - drug therapy | Cohort Studies | Medicine, Experimental | Medical research | Genetic aspects | Methylation | Gliomas | Analysis | Index Medicus
Journal Article
International journal of cancer, ISSN 0020-7136, 09/2016, Volume 139, Issue 6, pp. 1391 - 1401
WT1 IgG antibody | glioblastoma | predictive marker | WT1 peptide‐based immunotherapy | WT1 peptide-based immunotherapy | Glioblastoma | Predictive marker | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Immunoglobulin G - blood | Humans | Middle Aged | Vaccination | Male | Th1 Cells - immunology | Peptides - administration & dosage | Th1 Cells - metabolism | Young Adult | WT1 Proteins - chemistry | Immunoglobulin G - immunology | Immunotherapy | WT1 Proteins - immunology | Adult | Female | T-Lymphocytes, Cytotoxic - immunology | HLA-A24 Antigen - immunology | Enzyme-Linked Immunosorbent Assay | Cancer Vaccines - administration & dosage | Peptides - immunology | Treatment Outcome | Combined Modality Therapy | Glioblastoma - therapy | Cancer Vaccines - immunology | Glioblastoma - immunology | T-Lymphocytes, Cytotoxic - metabolism | Biomarkers | Cell Line, Tumor | Aged | Glioblastoma - mortality | Peptides | Glioblastoma multiforme | Patient outcomes | Immunoglobulin G | Antigens | Immunoglobulins | Immunization | Brain cancer | Index Medicus | Tumor Immunology and Microenvironment
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 6/2015, Volume 64, Issue 6, pp. 707 - 716
Newly diagnosed glioblastoma | Immunology | Medicine & Public Health | Immunological response | WT1 peptide vaccination | Oncology | Cancer Research | Temozolomide | Safe combination | Life Sciences & Biomedicine | Science & Technology | WT1 Proteins - administration & dosage | Dacarbazine - administration & dosage | Dacarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cancer Vaccines - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Combined Modality Therapy | Brain Neoplasms - drug therapy | WT1 Proteins - adverse effects | Disease Progression | Glioblastoma - therapy | Brain Neoplasms - immunology | Glioblastoma - immunology | Brain Neoplasms - therapy | Dacarbazine - analogs & derivatives | WT1 Proteins - immunology | Adult | Female | Glioblastoma - drug therapy | Cohort Studies | Cancer vaccines | Medical colleges | Safety and security measures | Peptides | Vaccination | Development and progression | Respiratory agents | Nephroblastoma | Glioblastoma multiforme | Index Medicus
Journal Article
Epigenetics & chromatin, ISSN 1756-8935, 01/2016, Volume 9, Issue 1, pp. 2 - 2
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 2014, Volume 289, Issue 34, pp. 23786 - 23795
Interferon-alpha - pharmacology | Humans | DNA Primers | Blotting, Western | Flow Cytometry | Carcinoma, Hepatocellular - pathology | Liver Neoplasms - metabolism | Cell Line, Tumor | Liver Neoplasms - pathology | Cell Cycle - drug effects | Real-Time Polymerase Chain Reaction | Carcinoma, Hepatocellular - metabolism | Receptor, Interferon alpha-beta - metabolism | Index Medicus | Signal Transduction | Cell Cycle | Cell Death | Interferon | Fucci | Apoptosis | Hepatocellular Carcinoma
Journal Article
European journal of pharmaceutical sciences, ISSN 0928-0987, 05/2013, Volume 49, Issue 2, pp. 199 - 205
Raloxifene | Glucuronidation | UDP-glucuronosyltransferase 1A8 (UGT1A8) | Genetic polymorphism | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Estrogen Antagonists - metabolism | Glucuronosyltransferase - genetics | Raloxifene Hydrochloride - metabolism | Sf9 Cells | Animals | Glucuronides - metabolism | Glucuronosyltransferase - chemistry | Humans | Bone Density Conservation Agents - metabolism | Polymorphism, Genetic | Spodoptera | Index Medicus
Journal Article